The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Article in Globe and Mail - immunotherapy - trial for ovarian cancer patients?

zenmama
zenmama CSN Member Posts: 29

Article in Globe and Mail.  Mentions ovarian cancer....  I don't think I came across this trial in my research, but maybe I missed it....

 http://www.theglobeandmail.com/life/health-and-fitness/health/scientists-unleash-the-power-of-immunotherapy-on-stubborn-cancers/article22371088/?click=sf_globefb

 "..., a participant in BioCanRx, is among those pursuing this third approach. This month she will begin an early phase trial, the first of its kind, to attempt adoptive cell therapy with ovarian-cancer patients. Like melanoma, it’s another form of the disease where options for treatment are limited, and there is potential for immunotherapy to make a big impact."